- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07784946
A Behavioural Sleep Intervention for People With Mild Cognitive Impairment and Mild Dementia
August 21, 2026 updated by: The Hong Kong Polytechnic University
A Behavioural Sleep Intervention Enabled by a Virtual Coach for People With Mild Cognitive Impairment and Mild Dementia: A Proof-of-concept Study
This is two arm pilot randomized controlled trial, with the intervention gorup receiving AI-supported behavioral sleep intervention and control group receiving usual care
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Shanshan Wang, PhD
- Phone Number: 27664696
- Email: shan-shan.wang@polyu.edu.hk
Study Locations
-
-
Hung Hom
-
Kowloon, Hung Hom, Hong Kong
- Recruiting
- The Hong Kong Polytechnic University
-
Contact:
- Shanshan Wang
- Phone Number: 27664696
- Email: shan-shan.wang@polyu.edu.hk
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- diagnosis of mild cognitive impairment or dementia with the global deterioration scale (GDS) score at 4 or lower; endorse one or more sleep problems; experience sleep issues an average of 3 or more nights per week over the past month; reachable by phone; ability to provide informed consent and willingness to participate in the study.
Exclusion Criteria:
- have a prior diagnosis of a primary sleep disorder (e.g., sleep apnoea); have a severe chronic illness that may cause sleep problems (e.g., emphysema); currently receiving medical, psychological, or psychiatric treatment for sleep disturbance or depression; severe visual or hearing impairment; uncontrolled medical conditions that may interfere with participation.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention
The intervention group will receive 6 weekly sessions of AI-supported behavioural sleep intervention, including 6 group sessions and daily use of AI-sleep companion.
They can still receive usual care provided by community services
|
Participants will receive 6 weekly sessions of group education and daily use of the AI sleep companion
|
|
Other: Control
The control group will only receive usual care provided by community services
|
Usual care
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sleep disturbance
Time Frame: Baseline, immediately post-intervention (6 weeks)
|
Sleep quality will be assessed using the Pittsburgh Sleep Quality Index (PSQI).
Higher scores indicate poorer sleep quality.
|
Baseline, immediately post-intervention (6 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Dysfunctional beliefs and attitudes about sleep
Time Frame: Baseline and immediately post-intervention
|
The Dysfunctional Beliefs and Attitudes about Sleep scale will be used
|
Baseline and immediately post-intervention
|
|
Emotional distress
Time Frame: Baseline and immediately post-intervention
|
will be measured with the Depression, Anxiety, and Stress-21 Scale
|
Baseline and immediately post-intervention
|
|
Cognitive function
Time Frame: Baselin and immediately post-intervention
|
Montreal Cognitive Assessment (MoCA) 5-min Hong Kong version will be used
|
Baselin and immediately post-intervention
|
|
Health related quality of life
Time Frame: Baseline and immediately post-intervention
|
EQ-5D will be used
|
Baseline and immediately post-intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2026
Primary Completion (Estimated)
July 1, 2027
Study Completion (Estimated)
July 1, 2027
Study Registration Dates
First Submitted
August 21, 2026
First Submitted That Met QC Criteria
August 21, 2026
First Posted (Actual)
August 25, 2026
Study Record Updates
Last Update Posted (Actual)
August 25, 2026
Last Update Submitted That Met QC Criteria
August 21, 2026
Last Verified
August 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- P0054797
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.